LAMPERTICO, PIETRO
LAMPERTICO, PIETRO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA
2025 G.P. Caviglia, P. Fariselli, R. D'Ambrosio, P. Colombatto, E. Degasperi, G. Ricco, M.L. Abate, G. Birolo, G. Troshina, F. Damone, B. Coco, D. Cavallone, R. Perbellini, S. Monico, G.M. Saracco, M.R. Brunetto, P. Lampertico, A. Ciancio
Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48
2025 T. Asselah, P. Lampertico, S. Aleman, M. Bourlière, A. Streinu-Cercel, P. Bogomolov, V. Morozov, T. Stepanova, S. Lazar, D. Manuilov, R. Mercier, S. Tseng, L. Ye, J.F. Flaherty, A. Osinusi, B.L. Da, G.M. Chee, A.H. Lau, M.R. Brunetto, H. Wedemeyer
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study
2025 M. Iavarone, E. Alimenti, M. Puoti, H. Hasson, B. Monti, S. Bhoori, F. Peracchi, A. Siribelli, M. Fava, M. Bruccoleri, M. Merli, G. Morsica, A. De Silvestri, P. Bonfanti, A. Castagna, A. Soria, P. Lampertico
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
2025 M. Buti, J. Heo, Y. Tanaka, P. Andreone, M. Atsukawa, J. Cabezas, E. Chak, C.S. Coffin, K. Fujiwara, N. Gankina, S.C. Gordon, E. Janczewska, A. Komori, P. Lampertico, S. Mcpherson, V. Morozov, R. Plesniak, S. Poulin, P. Ryan, O. Sagalova, G. Sheng, N. Voloshina, Q. Xie, H.J. Yim, S. Dixon, M. Paff, L. Felton, M. Lee, T. Greene, J. Lim, D. Lakshminarayanan, G. Mcgonagle, H. Plein, A.S. Youssef, R. Elston, S. Kendrick, D. Theodore
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg‐IFNα‐2a as Treatment for Chronic Hepatitis Delta
2025 P. Lampertico, P.O. Bogomolov, V. Chulanov, T. Stepanova, V. Morozov, L. Allweiss, M. Dandri, J. Burhenne, A. Blank, S. Ciesek, C. Elsner, U. Dittmer, Q. An, D. Manuilov, B.L. Da, J.F. Flaherty, S. Urban, H. Wedemeyer
The impact of BCLC recommendations on survival for patients with hepatocellular carcinoma
2025 M. Iavarone, E. Alimenti, L. Canova, M. Bruccoleri, B. Antonelli, A.M. Ierardi, A. Sangiovanni, G. Cabibbo, A. De Silvestri, L. Caccamo, G. Carrafiello, P. Lampertico
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV
2025 M.P. Anolli, S. Uceda Renteria, E. Degasperi, F. Facchetti, D. Sambarino, M. Borghi, R. Perbellini, R. Soffredini, S. Monico, A. Callegaro, P. Lampertico
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study
2025 G. Caviglia, A. Ferro, R. D'Ambrosio, R. Perbellini, P. Lampertico, G. Periti, L. Valenti, C. Ciccioli, G. Pennisi, S. Petta, L. Brodosi, M. Petroni, F. Marchignoli, L. Pironi, A. Sagripanti, M. Argenziano, G. Svegliati-Baroni, C. Rosso, F. Barutta, A. Armandi, G. Gruden, E. Bugianesi
Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy
2025 A. Mhlanga, O. Wasserman, P. Lampertico, S.J. Cotler, H. Dahari
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of Cholestasis
2025 V. Calvaruso, C. Celsa, L. Cristoferi, M. Scaravaglio, R. Smith, S. Kaur, G. Di Maria, L. Capodicasa, G. Pennisi, A. Gerussi, E. Nofit, F. Malinverno, P. Lampertico, N. Cazzagon, M. Marzioni, U. Vespasiani-Gentilucci, F. Colapietro, P. Andreone, A.L. De Nalda, C. Rigamonti, M. Viganò, E.G. Giannini, M. Russello, E. Vanni, F. Cerini, A. Orlandini, M. Brunetto, G.A. Niro, G. Vettori, A. Castellaneta, V. Cardinale, D. Alvaro, A. Mega, V.P. Palitti, V. Cossiga, F. Morisco, F. Bellanti, L. Baiocchi, L. Fabris, M. Persico, E. Degasperi, S. Labanca, E. Bonaiuto, F. Pezzato, A. Federico, S. Petta, V. Di Marco, G.F. Mells, E. Culver, P. Invernizzi, C. Cammà, M. Carbone
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide
2025 M. Buti, H. Wedemeyer, S. Aleman, V. Chulanov, V. Morozov, O. Sagalova, T. Stepanova, R.G. Gish, A. Lloyd, A.M. Kaushik, V. Suri, D. Manuilov, A.O. Osinusi, J.F. Flaherty, P. Lampertico
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors
2025 N. Zignani, A. Costantino, M. Sagasta, C. Dibenedetto, R. Perbellini, S.C. Uceda Renteria, P. Lampertico, M. Francesca Donato
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib
2024 M. Iavarone, E. Alimenti, T. Tada, S. Shimose, G. Suda, C. Yoo, C. Soldà, F. Piscaglia, G. Tosetti, F. Marra, C. Vivaldi, F. Conti, M. Schirripa, H. Iwamoto, T. Sho, S.H. Lee, M.D. Rizzato, M. Tonnini, M. Rimini, C. Campani, G. Masi, F. Foschi, M. Bruccoleri, T. Kawaguchi, T. Kumada, A. Hiraoka, M. Atsukawa, S. Fukunishi, T. Ishikawa, K. Tajiri, H. Ochi, S. Yasuda, H. Toyoda, T. Hatanaka, S. Kakizaki, K. Kawata, F. Tada, H. Ohama, N. Itokawa, T. Okubo, T. Arai, M. Imai, A. Naganuma, A. Casadei-Gardini, P. Lampertico
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort
2024 L. A Kondili, G. Brancaccio, M. Elena Tosti, B. Coco, M. Giovanna Quaranta, V. Messina, A. Ciancio, F. Morisco, V. Cossiga, E. Claar, V. Rosato, M. Ciarallo, I. Cacciola, F. Romana Ponziani, L. Cerrito, R. Coppola, F. Longobardi, E. Biliotti, A. Rianda, F. Barbaro, N. Coppola, M. Stanzione, F. Barchiesi, S. Fagiuoli, M. Viganò, M. Massari, F. Paolo Russo, A. Ferrarese, D. Laccabue, V. Di Marco, P. Blanc, A. Marrone, G. Morsica, A. Federico, D. Ieluzzi, A. Rocco, F. Giuseppe Foschi, A. Soria, I. Maida, L. Chessa, M. Milella, E. Rosselli Del Turco, S. Madonia, L. Chemello, I. Gentile, P. Toniutto, M. Bassetti, L. Surace, L. Baiocchi, A. Pellicelli, A. De Santis, M. Puoti, E. Degasperi, G. Anna Niro, A. Linda Zignego, A. Craxi, G. Raimondo, T. Antonia Santantonio, M. Rossana Brunetto, G. Battista Gaeta, A. Aghemo, C. Baiguera, P.M. Battezzati, S. Battistella, M. Grazia Bavetta, C. Bertoni, C. Boni, P. Brambilla, A. Bray, F. Briano, E. Carmenini, F. Castelli, L. Cavalletto, F. Cerini, L. Chidichimo, E. Colella, G. Cologni, S. Como, R. Corsini, C. Costa, R. Cotugno, S. Cretella, F. De Angelis, P. De Leo, G. Di Perri, E. Falbo, L. Ferrigno, E. Fornasiere, D. Francisci, P. Gatti, P. Lampertico, I. Lenci, A. Licata, I. Maida, A. Marzano, A. Mastroianni, C. Mazzaro, M. Monti, G. Nardone, L. Ambra Nicolini, N. Passigato, M. Bruna Pasticci, P. Pierotti, B. Pinchera, T. Pollicino, C. Porcu, G. Quartini, G. Rancatore, M. Romeo, M. Grazia Rumi, A. Saracino, O. Schioppa, I. Serio, R. Soffredini, X. Tata, M. Tizzani, M. Tonnini, C. Torti, D. Valenti, S. Zaltron, A. Zoncada
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine
2024 L.C. Morlacchi, G. Alicandro, S. Uceda Renteria, N. Zignani, G. Giacomel, V. Rossetti, M. Sagasta, G. Citterio, A. Lombardi, C. Dibenedetto, B. Antonelli, L. Rosso, P. Lampertico, F. Ceriotti, F. Blasi, M.F. Donato
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta
2024 E. Degasperi, C. Scholtes, B. Testoni, S.U. Renteria, M.P. Anolli, C. Charre, F. Facchetti, M. Plissonnier, D. Sambarino, R. Perbellini, S. Monico, A. Callegaro, E. García-Pras, S. Lens, M.F. Cortese, X. Forns, S. Pérez-Del-Pulgar, M. Heil, M. Levrero, F. Zoulim, P. Lampertico
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
2024 L. Shekhtman, S.J. Cotler, E. Degasperi, M.P. Anolli, S.C. Uceda Renteria, D. Sambarino, M. Borghi, R. Perbellini, F. Facchetti, F. Ceriotti, P. Lampertico, H. Dahari
Comprehensive investigation of platelet function in patients with cirrhosis
2024 A. Lecchi, G. Tosetti, C. Ghali, S. La Marca, M. Clerici, L. Padovan, E.A. Femia, M. Primignani, V. La Mura, P. Lampertico, F. Peyvandi, A. Tripodi
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis
2024 A. Tripodi, M. Primignani, R. D'Ambrosio, G. Tosetti, V. La Mura, P. Lampertico, F. Peyvandi
JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2
2024 K. Agarwal, M. Buti, F. Van Bömmel, P. Lampertico, E. Janczewska, M. Bourliere, T. Vanwolleghem, O. Lenz, T. Verbinnen, T.N. Kakuda, C. Mayer, J. Jezorwski, D. Muenz, M. Beumont, R. Kalmeijer, M. Biermer, I. Lonjon-Domanec